HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
HCW Biologics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.23−0.01 (-0.81%)
Close on Oct 19, 2026
- Market cap
- $1.63M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of HCW Biologics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Proxy statement | DEF 14A | Oct 1, 2026 | Oct 1, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2026 | Sep 24, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 10, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 4, 2026 | Sep 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2026 | Aug 14, 2026 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Mar 31, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2026 | Jul 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 29, 2026 | Jun 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2026 | Jun 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | Jun 1, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 27, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 21, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2026 | Apr 30, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 28, 2026 | Apr 28, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2026 | Apr 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Mar 31, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 31, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 17, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 13, 2026 | Mar 13, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Mar 2, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 13, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2025 | Dec 31, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 19, 2025 | Nov 20, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 17, 2025 | Nov 19, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 17, 2025 | Nov 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 13, 2025 | Oct 16, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2025 | Aug 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 18, 2025 | SEC EDGAR |